Syndi Health
AcquiredEntrepreneur First '21London, GB · Founded 2021 · 4 known investors
Syndi (HealthKey) operates a platform that connects organisations and their employees or customers to a network of vetted healthcare providers, offering services such as nutrition support, MSK triage, therapy, physiotherapy, and at-home testing. It targets employers, insurers, and gyms in the UK, letting them add branded, value-added health benefits with negotiated enterprise rates.
Also known as HealthKey · Syndi · Syndi LTD.
Founders & leadership
Syndi Health was founded in 2021 by Benjamin Lakey and Jorge Alexander.
Investors · 4
Also in the syndicate · 3
Company profile
researched Aug 2026Syndi Health (legal entity Syndi LTD.) was a London-based digital health company that built infrastructure to aggregate, recommend, pay for and monitor point-of-care digital health services. Its platform assessed users and matched them to third-party wellbeing apps, telemedicine services and digital therapeutics, with the stated aim of reducing trial-and-error in digital health selection and guiding people to support earlier in their health journeys. For organisations, the product included a dashboard for tracking health and wellbeing data, budget allocation and vendor management tools, and payment handling; in some descriptions the employee-facing budget was delivered via a virtual credit or payment card system.
The company described its model as a bundled, subscription-style all-access package of digital health services that could be self-paid, co-paid or reimbursed, integrated into high-traffic distribution channels such as student discount platforms, charity websites and online communities. It also emphasised AI-driven personalisation trained on health data from users' smartphones and transaction data from its virtual payment card, plus privacy-by-design practices (including DPIAs) intended to meet NHS and GDPR requirements for clinical trial collaborations.
Syndi Health was acquired by HealthKey, finalised 1 May 2025 and reported publicly in June 2025. HealthKey operates a flexible health and wellbeing marketplace for employers, gyms and leisure operators, and insurers, offering access to a network of vetted healthcare providers, health budgets, care bundles and white-label branding. The syndi.health domain now presents HealthKey's platform.
Founding story
Multiple sources state the company was founded in 2020 in London by Ben Lakey and Jorge Alexander (internal records list 2021). The founders' stated motivation was personal frustration with delayed access to care — one account cites waiting over 10 months to access mental health support — and the difficulty individuals face navigating a fragmented digital healthcare market. The company had early backing from the Entrepreneur First accelerator.
Business model
B2B/B2B2C: Syndi Health licensed its platform to employers, healthcare providers and insurers, which offered aggregated digital health services to employees, patients or customers. It also worked through consumer distribution channels such as student discount platforms and charity websites. Post-acquisition, the HealthKey platform is sold to employers, gyms and leisure centres, and insurers, positioned as a no-platform-fee, flexible-pricing model with enterprise rates negotiated through aggregated buying power.
In 2022 the company stated it retained 10% of all lifetime transactions to digital health services made by referred users, alongside subscription bundles that could be self-paid, co-paid or reimbursed. It also described an extensive pipeline of licensing customers as of early 2023. The successor HealthKey platform advertises no platform fee and flexible pricing.
Traction
By February 2023 the company reported over 20,000 users onboarded from more than 1,300 schools, universities and colleges in the UK and US via student platforms, partnerships with over 40 digital health services, a licensing pipeline, and a pilot contract with one of the largest UK healthcare charities. It also held an NHS validation project funded by an Innovate UK Biomedical Catalyst grant. HealthKey, which acquired the company, reports access to 75 healthcare providers and cites deployment results with F45 (18% of members registered in the first month, 49% accessed care) and insurer Eleos (39% of new customers booked a session), plus a customer case study involving Aviva.
Latest developments
HealthKey completed its acquisition of Syndi Health on 1 May 2025, taking on a number of Syndi customers and planning to integrate Syndi's clinical assessment technology into the HealthKey platform, with enhanced personalisation to be rolled out to HealthKey users. Ben Lakey became HealthKey's director of operations. The syndi.health domain now hosts HealthKey's platform marketing, referencing access to 75 vetted healthcare providers and customer deployments with F45, Eleos and Aviva.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Positioned as an aggregation and navigation layer in a fragmented digital health market that one source characterised as containing over 350,000 consumer wellbeing apps, telemedicine services and digital therapeutics. It targeted the employee wellbeing and preventative care segment, and had secured partnerships with more than 40 digital health services by February 2023 before being absorbed into HealthKey's marketplace.
Sources cite clinical assessment technology (described as patented and medically approved) paired with AI-driven personalised recommendations, a payments and outcome-monitoring layer for point-of-care services, and privacy/compliance practices designed for NHS and GDPR-regulated collaborations. HealthKey's stated rationale for the acquisition was that HealthKey handled marketplace integration and due diligence while Syndi Health excelled at clinical assessment and personalisation.
Technology
An AI/machine-learning recommendation and clinical assessment engine that matches users to suitable digital health services, combined with payment infrastructure (a virtual payment card), outcome monitoring and organisational analytics. Sources describe use of smartphone health data and payment data to personalise recommendations, an intent to build a digital health efficacy dataset, and privacy-by-design controls such as DPIAs for clinical trial work. The assessment technology is described as patented and medically approved, and was recognised by an Innovate UK Biomedical Catalyst grant.
Go-to-market
Sold via organisations rather than direct to consumer: pilots and licensing contracts with employers, insurers and healthcare providers, including a pilot contract with one of the largest UK healthcare charities and an NHS validation project with Cornwall Partnership NHS Foundation Trust and the University of Plymouth. Early distribution came from integrating with high-traffic channels such as student discount platforms. The company also used accelerator and pitch platforms (Entrepreneur First, Elevating Founders Europe 2022 at London Tech Week) for investor and partner visibility.
Employers and HR/wellbeing teams, health insurers, healthcare providers and NHS trusts, healthcare charities, and gyms and leisure centres; end users are employees, insurance customers, gym members, patients and (in the earlier phase) students.
Geography
Headquartered in London, United Kingdom (an aggregator listing gives an address at Floor 4, 29 Martin Lane, London EC4R 0DJ). Operations and partnerships were primarily UK-focused (NHS trusts, UK employers and insurers), with early student-platform users in both the UK and the United States. Investors included US-based Plug and Play and Remus Capital.
History
Founded 2020 in London; launched initially through student discount platforms, onboarding over 20,000 users across more than 1,300 UK and US educational institutions. A 2021 partnership with GATC Health was reported for AI training on disease detection datasets. The company pitched at Elevating Founders Europe 2022 during London Tech Week ahead of a planned seed round. In February 2023 it announced a $2 million oversubscribed pre-seed of equity and grant funding, alongside a £400,000 Innovate UK Biomedical Catalyst grant with the University of Plymouth and Cornwall Partnership NHS Foundation Trust for an 18-month NHS validation. On 1 May 2025 the company was acquired by HealthKey, with the deal reported publicly in June 2025 and CEO Ben Lakey joining HealthKey as director of operations.
Risks & controversies
No controversies are reported in the available sources. Data quality caveats exist: sources disagree on founding year (2020 in press coverage versus 2021 in internal records), and one aggregator listing contains implausible or unverified details (employee count of 1,001-5,000 and $4.1M raised across two rounds) that are not corroborated by primary coverage. Publicly reported funding is limited to a $2M pre-seed plus grant, and the company ceased to exist independently following the 2025 acquisition.
Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 5
launches, deals, and filingsHealthKey, a healthcare marketplace platform, acquired Syndi Health in a deal finalised on 1 May 2025 and reported on 4 June 2025. HealthKey took on a number of Syndi Health's customers and plans to integrate Syndi's patented, medically approved clinical assessment and AI-driven recommendation technology into its marketplace platform. Syndi co-founder and CEO Ben Lakey joined HealthKey as director of operations.
Oversubscribed pre-seed round of $2 million in equity and grant funding, with proceeds directed at platform development, team growth, B2B customer acquisition, and pilots with public and private healthcare providers and employee benefit programmes.
$2M source ↗
Syndi Health won a £400,000 Innovate UK grant under the Biomedical Catalyst programme, in collaboration with the University of Plymouth and Cornwall Partnership NHS Foundation Trust, to validate the platform within the NHS over 18 months.
Reported partnership with GATC Health to accelerate AI training using Syndi datasets for disease detection work in diabetes and heart health.
Syndi Health launched its solution with student platforms, onboarding over 20,000 users from more than 1,300 schools, universities and colleges in the UK and US.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 7
primary sources listed
- Syndi Healthsyndi.health · web
7 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Syndi Health do?
- UK digital health platform matching users to vetted health services; acquired by HealthKey in May 2025.
- Who founded Syndi Health?
- Syndi Health was founded by Benjamin Lakey, Jorge Alexander in 2021.
- Who are Syndi Health's investors?
- Syndi Health's investors include Entrepreneur First.
- Where is Syndi Health headquartered?
- Syndi Health is headquartered in London, GB.

